Literature DB >> 16162162

High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase.

Rie Sugimoto1, Munechika Enjoji, Motoyuki Kohjima, Satoshi Tsuruta, Marie Fukushima, Masataka Iwao, Toshiyo Sonta, Kazuhiro Kotoh, Toyoshi Inoguchi, Makoto Nakamuta.   

Abstract

BACKGROUND: Nonalcoholic steatohepatitis is a clinicopathologic condition that may progress to liver fibrosis. Hyperglycemia is supposed to be one of the factors inducing hepatic fibrogenesis, but the mechanism has not been fully clarified. Oxidative stress is increasingly found in patients with diabetes/hyperglycemia in which conditions reactive oxygen species (ROS) are produced.
METHODS: We performed experiments using hepatic stellate cells (HSCs) in culture in order to confirm the effect of high glucose concentrations on cell proliferation, type I collagen production, ROS production and activation of mitogen-activated protein (MAP) kinase pathway.
RESULTS: High glucose stimulated cell growth of HSCs and up-regulated the levels of activated/phosphorylated extracellular signal-regulated kinase 1/2 and free radical production in HSCs. The MAP kinase phosphorylation and cell proliferation were suppressed by diphenylene iodonium chloride, an NADPH oxidase inhibitor, and by calphostin C, a protein kinase C (PKC)-specific inhibitor. Increased type I collagen mRNA and protein levels were also observed in HSCs at high glucose concentrations.
CONCLUSIONS: Our findings indicate that high glucose concentrations may stimulate ROS production through PKC-dependent activation of NADPH oxidase, and induce MAP kinase phosphorylation subsequent to proliferation and type I collagen production by HSCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16162162     DOI: 10.1111/j.1478-3231.2005.01130.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  38 in total

1.  Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2.

Authors:  Jianguo Lin; Anping Chen
Journal:  Mol Cell Endocrinol       Date:  2010-12-30       Impact factor: 4.102

2.  Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase.

Authors:  Youcai Tang; Anping Chen
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Smad7 dependent expression signature highlights BMP2 and HK2 signaling in HSC transdifferentiation.

Authors:  Bernd Denecke; Lucia Wickert; Yan Liu; Loredana Ciuclan; Steven Dooley; Nadja M Meindl-Beinker
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

4.  CD8+ T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.

Authors:  Denitra A Breuer; Maria Cristina Pacheco; M Kay Washington; Stephanie A Montgomery; Alyssa H Hasty; Arion J Kennedy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-11-11       Impact factor: 4.052

5.  Purinergic receptor X7 mediates leptin induced GLUT4 function in stellate cells in nonalcoholic steatohepatitis.

Authors:  Varun Chandrashekaran; Suvarthi Das; Ratanesh Kumar Seth; Diptadip Dattaroy; Firas Alhasson; Gregory Michelotti; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Biochim Biophys Acta       Date:  2015-10-22

6.  NADPH Oxidases in Chronic Liver Diseases.

Authors:  Joy X Jiang; Natalie J Török
Journal:  Adv Hepatol       Date:  2014-11-30

Review 7.  Can NASH be diagnosed, graded, and staged noninvasively?

Authors:  Garfield A Grandison; Paul Angulo
Journal:  Clin Liver Dis       Date:  2012-06-26       Impact factor: 6.126

Review 8.  Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.

Authors:  Briohny W Smith; Leon A Adams
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

9.  Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.

Authors:  Norihisa Nishimura; Mitsuteru Kitade; Ryuichi Noguchi; Tadashi Namisaki; Kei Moriya; Kosuke Takeda; Yasushi Okura; Yosuke Aihara; Akitoshi Douhara; Hideto Kawaratani; Kiyoshi Asada; Hitoshi Yoshiji
Journal:  J Gastroenterol       Date:  2016-03-29       Impact factor: 7.527

10.  Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis.

Authors:  Erika Hamaguchi; Toshinari Takamura; Masaru Sakurai; Eishiro Mizukoshi; Yoh Zen; Yumie Takeshita; Seiichiro Kurita; Kuniaki Arai; Tatsuya Yamashita; Motoko Sasaki; Yasuni Nakanuma; Shuichi Kaneko
Journal:  Diabetes Care       Date:  2009-10-30       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.